EcoDrugPlus

Toll Like Receptor 7

Ensembl ID : ENSTRUG00000008051
Gene Symbol: TLR7
3 Cross references
197 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSTRUG00000026196
Gene Symbol: TAAR1
1 Cross references
353 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSTRUG00000025464
Gene Symbol: TAAR1
1 Cross references
367 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSTRUG00000004890
Gene Symbol: TAAR1
3 Cross references
329 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSTRUG00000004891
Gene Symbol: TAAR1
3 Cross references
387 Possible Orthologues:

Transient Receptor Potential Cation Channel, Subfamily A, Member 1b

Ensembl ID : ENSTRUG00000012435
Gene Symbol: TRPA1B
1 Cross references
200 Possible Orthologues:

Transthyretin-Like

Ensembl ID : ENSTRUG00000021323
Gene Symbol: LOC101068436
3 Cross references
178 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSTRUG00000022357
Gene Symbol: TUBA4A
4 Cross references
156 Possible Orthologues:

Tubulin Alpha Chain-Like

Ensembl ID : ENSTRUG00000033060
Gene Symbol: LOC101061990
2 Cross references
170 Possible Orthologues:

Tubulin Beta-2a Chain

Ensembl ID : ENSTRUG00000030757
Gene Symbol: LOC101062287
3 Cross references
305 Possible Orthologues:

Tubulin Beta-6 Chain

Ensembl ID : ENSTRUG00000013246
Gene Symbol: LOC101072579
3 Cross references
184 Possible Orthologues:

Tubulin, Beta 5

Ensembl ID : ENSTRUG00000012143
Gene Symbol: TUBB5
1 Cross references
221 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).